000 | 01640 a2200421 4500 | ||
---|---|---|---|
005 | 20250513105035.0 | ||
264 | 0 | _c19970108 | |
008 | 199701s 0 0 eng d | ||
022 | _a0022-1899 | ||
024 | 7 |
_a10.1093/infdis/174.6.1249 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBucklin, S E | |
245 | 0 | 0 |
_aBacteremia versus endotoxemia in experimental mouse leukopenia--role of antibiotic chemotherapy. _h[electronic resource] |
260 |
_bThe Journal of infectious diseases _cDec 1996 |
||
300 |
_a1249-54 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
650 | 0 | 4 |
_aBacteremia _xdrug therapy |
650 | 0 | 4 |
_aCeftazidime _xtherapeutic use |
650 | 0 | 4 |
_aCephalosporins _xtherapeutic use |
650 | 0 | 4 |
_aCyclophosphamide _xadverse effects |
650 | 0 | 4 |
_aEndotoxemia _xdrug therapy |
650 | 0 | 4 |
_aEscherichia coli _ximmunology |
650 | 0 | 4 |
_aEscherichia coli Infections _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGalactosamine _xadverse effects |
650 | 0 | 4 |
_aImipenem _xtherapeutic use |
650 | 0 | 4 | _aImmunity, Innate |
650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
650 | 0 | 4 |
_aLeukopenia _xchemically induced |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aO Antigens _xadministration & dosage |
650 | 0 | 4 |
_aThienamycins _xtherapeutic use |
700 | 1 | _aMorrison, D C | |
773 | 0 |
_tThe Journal of infectious diseases _gvol. 174 _gno. 6 _gp. 1249-54 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/infdis/174.6.1249 _zAvailable from publisher's website |
999 |
_c8932545 _d8932545 |